haloperidol has been researched along with bupropion in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (17.65) | 18.7374 |
| 1990's | 4 (11.76) | 18.2507 |
| 2000's | 9 (26.47) | 29.6817 |
| 2010's | 15 (44.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Brown, EE; Cumming, P; Damsma, G; Fibiger, HC | 1 |
| Balsara, JJ; Kop, PB; Muley, MP | 1 |
| Loskutova, LV; Luk'ianenko, FIa | 1 |
| Bergman, J; Spealman, RD | 1 |
| Dahms, JL; Seiden, LS; Shaughnessy, RA | 1 |
| Trulson, ME | 1 |
| Ortmann, R | 1 |
| Goode, DJ; Manning, AA | 1 |
| Carter, RG; Manberg, PJ | 1 |
| Gazzara, RA; Gough, B; Holson, RR | 1 |
| Admiraal, P; de Graaf, L; van Puijenbroek, EP | 1 |
| Kalgutkar, AS; Nguyen, HT | 1 |
| Gur, RE; Kanes, SJ; Lerman, C; Liang, Y; Majumdar, S; Maxwell, CR; Siegel, SJ; Trief, DF | 1 |
| Gerak, LR; Moerschbaecher, JM; Quinton, MS; Winsauer, PJ | 1 |
| Harvey, I; Lilford, R; Song, F | 1 |
| Lipina, T; Roder, J | 1 |
| Balci, F; Campbell, U; Hanania, T; Olivier, BE; Paterson, NE | 1 |
| Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE | 1 |
| Boušová, I; Matoušková, P; Skálová, L; Souček, P | 1 |
| McAllister, MW; Woodhall, DM | 1 |
3 review(s) available for haloperidol and bupropion
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome | 2008 |
The modulation of carbonyl reductase 1 by polyphenols.
Topics: Alcohol Oxidoreductases; Animals; Bupropion; Butanones; Butyrophenones; Daunorubicin; Doxorubicin; Gene Expression Regulation, Enzymologic; Haloperidol; Humans; Indoles; Nabumetone; Neoplasms; Phenylpropionates; Polyphenols; Quinolizines; Substrate Specificity; Xenobiotics | 2015 |
1 trial(s) available for haloperidol and bupropion
| Article | Year |
|---|---|
Comparison of bupropion alone and with haloperidol in schizo-affective disorder, depressed type.
Topics: Adolescent; Adult; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Outcome and Process Assessment, Health Care; Propiophenones; Psychiatric Status Rating Scales; Psychotic Disorders | 1983 |
30 other study(ies) available for haloperidol and bupropion
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Antidepressive Agents; Apomorphine; Bupropion; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Kinetics; Male; Propiophenones; Rats; Rats, Inbred Strains; Tetrodotoxin | 1991 |
Differential effect of bupropion on haloperidol and morphine catalepsy in the rat.
Topics: Animals; Antidepressive Agents; Bupropion; Catalepsy; Female; Haloperidol; Male; Morphine; Propiophenones; Rats | 1990 |
[Specifics of participation of dopaminergic and serotoninergic systems of the brain in latent inhibition based on pharmacological models].
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Avoidance Learning; Brain; Bupropion; Dopamine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol.
Topics: Animals; Bupropion; Cocaine; Conditioning, Operant; Cyproheptadine; Desipramine; Diazepam; Dose-Response Relationship, Drug; Electroshock; Haloperidol; Histamine H1 Antagonists; Male; Propiophenones; Saimiri | 1988 |
Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.
Topics: Animals; Antidepressive Agents; Bupropion; Clozapine; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Trazodone; Zimeldine | 1985 |
Activity of dopamine-containing substantia nigra neurons in freely moving cats.
Topics: Action Potentials; Animals; Apomorphine; Brain Mapping; Bupropion; Cats; Circadian Rhythm; Dextroamphetamine; Dopamine; Female; Haloperidol; Lysergic Acid Diethylamide; Male; Propiophenones; Sensation; Sleep Stages; Substantia Nigra | 1985 |
The conditioned place preference paradigm in rats: effect of bupropion.
Topics: Animals; Bupropion; Conditioning, Psychological; Haloperidol; Male; Motor Activity; Propiophenones; Rats; Sulpiride | 1985 |
Bupropion in the treatment of psychotic depression: two case reports.
Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Propiophenones; Recurrence | 1984 |
Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Axotomy; Bupropion; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Male; Microdialysis; Potassium; Rats; Rats, Sprague-Dawley; Time Factors | 1998 |
Ballism associated with bupropion use.
Topics: Adult; Bupropion; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Oxazepam | 2003 |
Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antidiarrheals; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Dealkylation; Haloperidol; Humans; Hydroxylation; Ketoconazole; Loperamide; Male; Microsomes, Liver; NADP; Neurons; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Time Factors | 2004 |
Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Bupropion; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Evoked Potentials, Auditory; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia | 2005 |
Effects of pregnanolone in rats discriminating cocaine.
Topics: Animals; Bupropion; Cocaine; Desipramine; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Haloperidol; Male; Pregnanolone; Rats; Rats, Long-Evans; Receptors, GABA-A | 2006 |
A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.
Topics: Amphetamine; Animals; Bupropion; Clozapine; Conditioning, Psychological; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Interactions; Haloperidol; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Neural Inhibition; Phosphodiesterase 4 Inhibitors; Piperazines; Rolipram; Schizophrenic Psychology | 2010 |
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Topics: Animals; Antidepressive Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Desipramine; Diazepam; Dopamine Uptake Inhibitors; Fluvoxamine; Haloperidol; Imipramine; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology | 2011 |
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2016 |
Bupropion-induced stuttering treated with haloperidol.
Topics: Bupropion; Emergency Service, Hospital; Haloperidol; Humans; Male; Middle Aged; Stuttering | 2016 |